Vivalytic SARS-CoV-2 Dual Target

Vivalytic SARS-CoV-2 Dual Target

Point of Care Testing Device

Information

The Vivalytic SARS-CoV-2 Dual Target Test is a real-time PCR diagnostic assay designed to detect SARS-CoV-2 by targeting both the E-gene and N-gene sequences. It uses nasopharyngeal or oropharyngeal swabs (eNAT) as sample types and provides clear, concise results within 53 minutes. This rapid and point-of-care test enables individuals to take timely safety precautions and appropriate actions based on their results.
Randox Laboratories LtdS2.B10Randox is committed to improving health worldwide with the firm belief that the healthcare of tomorrow depends on innovations developed today. Our passion for innovation, creativity and investment in R&D enables us to continually develop our products and evolve for the future. As a world leader in the in-vitro diagnostics industry, Randox is committed to developing revolutionary diagnostic products designed to improve health globally including chemistry, immunoassay, molecular & POC analysers in addition to high quality reagents. Leading provider of complete quality control solutions including; daily quality control, calibration verification and proficiency testing for results you can trust. Biochip Array Technology is a unique multiplexing method offering clinical, research and molecular panels. We also offer a range of COVID-19 testing solutions for all testing needs. Randox is leading the change in moving from a one-size-fits-all approach towards decisions and products tailored to the needs of the individual.

Log in

See all the content and easy-to-use features by logging in or registering!